Jos Lamers holds a degree in Human Nutrition from Wageningen University, the Netherlands. Jos Lamers joined Unilabs in October 2013 as Chief Executive Officer. Prior to joining Unilabs, Mr. Lamers was CEO of Nucletron, a radiotherapy company and global leader in brachytherapy that was acquired by Elekta in 2011. He led the turn-around of Nucletron and subsequently oversaw its successful sale from private equity ownership to Elekta in 2011. Before that, Mr. Lamers was a Regional President and member of the Executive Management Board at Eurofins. Eurofins Scientific is the world leader in food and bio/ pharma products testing, as well as being one of the global market leaders in central laboratory services.His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Human Nutrition